Cited By
Citations to this article as recorded by
![](/image/icon/crossref2.gif)
Treatment of toxoplasmosis: Current options and future perspectives
Neda Konstantinovic, Hélène Guegan, Tijana Stäjner, Sorya Belaz, Florence Robert-Gangneux
Food and Waterborne Parasitology.2019; 15: e00036.
CrossRef Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity
Marijo S. Roiko, Kaice LaFavers, Diane Leland, Gustavo Arrizabalaga
International Journal for Parasitology.2018; 48(3-4): 225.
CrossRef Control of human toxoplasmosis
Nicholas C. Smith, Cibelly Goulart, Jenni A. Hayward, Andreas Kupz, Catherine M. Miller, Giel G. van Dooren
International Journal for Parasitology.2021; 51(2-3): 95.
CrossRef Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infection
Mohammad Mahdi Jafari, Zahra Azimzadeh Tabrizi, Mohammad Saaid Dayer, Nazanin Atieh Kazemi-Sefat, Mahshid Mohtashamifard, Rahimeh Mohseni, Atefeh Bagheri, Saeed Bahadory, Amir Karimipour-Saryazdi, Fatemeh Ghaffarifar
International Immunopharmacology.2023; 124: 110872.
CrossRef Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice
Majid Golkar, Mohammad-Ali Shokrgozar, Sima Rafati, Karine Musset, Mehdi Assmar, Reza Sadaie, Marie-France Cesbron-Delauw, Corinne Mercier
Protective Th1 immune responses against chronic toxoplasmosis induced by a protein–protein vaccine combination but not by its DNA–protein counterpart
E. Jongert, D. Verhelst, M. Abady, E. Petersen, N. Gargano
Interferon-γ-dependent protection against Neospora caninum infection conferred by mucosal immunization in IL-12/IL-23 p40-deficient mice
Pedro Ferreirinha, Ricardo Fróis-Martins, Luzia Teixeira, António Rocha, Manuel Vilanova, Alexandra Correia
Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital Toxoplasmosis
Anne di Tommaso, Matthieu O Juste, Zineb Lakhrif, Marie-Noëlle Mévélec, Coraline Borowczyk, Pierre Hammeni, Guillaume Désoubeaux, Nathalie Van Langendonck, Françoise Debierre-Grockiego, Nicolas Aubrey, Isabelle Dimier-Poisson
The Journal of Infectious Diseases.2021; 224(4): 705.
CrossRef Generation of a Neutralizing Human Monoclonal Antibody Fab Fragment to Surface Antigen 1 ofToxoplasma gondiiTachyzoites
Yong-Feng Fu, Meng Feng, Kenji Ohnishi, Tamon Kimura, Johbu Itoh, Xun-Jia Cheng, Hiroshi Tachibana, J. H. Adams
Infection and Immunity.2011; 79(1): 512.
CrossRef GRA Proteins of Toxoplasma gondii: Maintenance of Host-Parasite Interactions across the Parasitophorous Vacuolar Membrane
Ho-Woo Nam
The Korean Journal of Parasitology.2009; 47(Suppl): S29.
CrossRef Recent Advances in Toxoplasma gondii Immunotherapeutics
Sherene Swee-Yin Lim, Rofina Yasmin Othman
The Korean Journal of Parasitology.2014; 52(6): 581.
CrossRef Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice
Xiao T. Ching, Mun Y. Fong, Yee L. Lau
Frontiers in Microbiology.2016;[Epub]
CrossRef Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis
Shuai Wang, Zhenchao Zhang, Yujian Wang, Javaid A. Gadahi, Lixin Xu, Ruofeng Yan, Xiaokai Song, Xiangrui Li
Frontiers in Microbiology.2017;[Epub]
CrossRef A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis
Xiaowei Tian, Hanqi Sun, Meng Wang, Guangmin Wan, Tong Xie, Xuefang Mei, Zhenchao Zhang, Xiangrui Li, Shuai Wang
Frontiers in Veterinary Science.2022;[Epub]
CrossRef Plant-derived chimeric antibodies inhibit the invasion of human fibroblasts byToxoplasma gondii
Sherene Swee Yin Lim, Kek Heng Chua, Greta Nölke, Holger Spiegel, Wai Leong Goh, Sek Chuen Chow, Boon Pin Kee, Rainer Fischer, Stefan Schillberg, Rofina Yasmin Othman